Loading...
•
Dec 31, 2022
Penumbra Q4 2022 Earnings Report
Penumbra reported an 8.4% increase in revenue for Q4 2022, with vascular products growing by 14.2% and neuro products by 1.2%.
Key Takeaways
Penumbra, Inc. reported financial results for the fourth quarter and full year ended December 31, 2022. Total revenue increased to $221.2 million for the fourth quarter of 2022 compared to $204.0 million for the fourth quarter of 2021, an increase of 8.4%, or 10.5% in constant currency.
Total revenue increased to $221.2 million for the fourth quarter of 2022, an 8.4% increase compared to Q4 2021.
US revenue for Q4 2022 was $157.1 million, 8.8% above the same period a year ago.
Revenue from sales of vascular products grew to $129.7 million, a 14.2% increase.
Revenue from sales of neuro products grew to $91.5 million, a 1.2% increase.
Revenue by Geographic Location
Forward Guidance
Penumbra projects total revenue for 2023 to be $1 billion or more, representing year over year growth of at least 18%, which is an acceleration from 2022 revenue of $847 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...